Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Billionaire David Harding’s Top Stock Picks Pay High Yields

Winton Capital was founded by David Harding in 1997 and by the end of 2011 had grown to $28 billion under management. The fund has had an impressive performance over the last several years, with positive returns in 2008 and only slightly negative returns in 2009 before gains in the next two years. Winton’s 13F filing for the end of September discloses many of the long equity positions that it owned at that time, and investors can go through what the fund owned as a source of potential stock ideas. Read on for our quick thoughts on the fund’s largest holdings or see the full portfolio.

David Harding

Harding and his team’s top pick was Eli Lilly & Co. (NYSE:LLY), with Winton owning 1.1 million shares at the end of September. The large pharmaceutical company trades at 13 times earnings, on both a trailing and a forward basis. It’s also an excellent defensive stock with a beta of 0.4 and a dividend yield above 4% at current prices. While revenue was down last quarter compared to a year earlier, earnings were up. We’re interested in what we see here and think that we might take a closer look at the company. Andreas Halvorsen’s Viking Global also liked the stock during the third quarter, reporting a position of 4.9 million shares (find more stocks that Viking Global owns).

Philip Morris International Inc. (NYSE:PM) was another of the fund’s favorite stocks as it increased its stake 42% to about 540,000 shares. The company sells Philip Morris brands of cigarettes such as Marlboro in international markets. It’s another intriguing income stock at a 4% dividend yield, though its financials are slipping (likely due to poor demand in Europe). Its trailing P/E is 17. Billionaire Ken Fisher’s Fisher Asset Management more than doubled the size of its own position in Philip Morris last quarter (see more of Ken Fisher’s stock picks). We think that other cigarette companies also offer good yields and might make better values.

Another of the fund’s top picks was Consolidated Edison, Inc. (NYSE:ED), which at current prices pays a 4.4% yield. The $16 billion market cap electric utility trades at 14 times trailing earnings, and as might be expected for a utility marries its high dividend yield to a low beta (0.1). As a result it looks like a very good defensive stock or income generator. We might also consider Con Ed against other utilities on a value basis, given the low multiple. Winton reported owning about 800,000 shares at the end of September.

Winton also bought shares of Verizon Communications Inc. (NYSE:VZ), another high yield stock (the dividend yield is about 5% here). The fund owned about 840,000 shares of the telecom. At a market capitalization of just over $120 billion, it carries trailing and forward P/Es of 40 and 15, respectively, as sell-side analysts promise strong earnings growth in 2013. Net income in the third quarter was 16% higher than in the same period in 2011, but the gap in the earnings multiples is still high enough that we think we’d avoid the stock.

Continuing the streak of companies with generous payout policies was Public Service Enterprise Group Inc. (NYSE:PEG). The company is a diversified utility providing electricity and natural gas in the northeastern and mid-Atlantic U.S. As with Con Ed, it’s unsurprising to see a low beta (0.3) and a high dividend yield (4.8%) at a utility. It trades at 11 times trailing earnings, a discount to Con Ed, though Wall Street analysts actually expect a small decrease in earnings in 2013. Again, we’d be interested in comparing it to other utilities to see if it might be a good buy.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!